{"prompt": "['Amended Clinical Trial Protocol NO 03', '18-Apr-2018', 'ACT14656', 'Version number: 1', 'Labeling of specimens:', '-', 'Each sample tube should have attached to it the label provided by Covance,', 'DNA Subject ID:XXX-001-YYY', 'ACT14656 /SAR407899 (preprinted)', 'Bar code (preprinted)', 'Accession number (preprinted)', '-', 'In the event of damage or loss of the provided labels, a new label should be', 'immediately requested from Covance.', 'Storage', '-', 'Samples must be kept at - -70 \u00b0C or colder, organized in a rack in numeric order', 'according to the subject ID, until ready for packaging and shipping.', '3.', 'PACKAGING AND SHIPMENT OF DNA PHARMACOGENETIC ANALYSIS', '3.2', 'DNA for pharmacogenetic analysis sample', '3.2.1', 'Packaging and shipment', '-', 'Samples and accompanying documents should be packaged according to the detailed', 'instructions in Covance laboratory manual provided at the initiation of the study.', '-', 'Samples must be packaged according to IATA Dangerous Goods Regulations, Packing', 'Instructions 650, using the packing materials provided by Covance.', '-', 'In the event that the packaging materials or instructions are lost, please contact the', 'study Sponsor.', '-', 'Ship samples on dry ice to Covance as described in the Global Study Schedule, using', 'the shipping materials provided.', 'Note: Additional detailed information can be found in Covance laboratory manual, provided at', 'the beginning of the study. This includes additional details regarding:', '-', 'Sample collection kits.', '-', 'Sample collection procedures.', '-', 'Documentation procedures.', '-', 'Packing and shipping instructions.', '-', 'Sample kit resupply.', '-', 'How to get help.', 'Property of the Sanofi Group - strictly confidential', 'Page 103', '(electronic 4.0)']['Amended Clinical Trial Protocol NO 03', '18-Apr-2018', 'ACT14656', 'Version number: 1', '4.', 'SHIPMENT CONTACT NAMES AND ADDRESSES', 'Pharmacogenetic specimens for DNA storage:', 'Use for the Americas: USA and Canada, as well as Latin America and the Islands (Dominican', 'Republic, etc):', 'Covance CLS Indianapolis', '8211 SciCor Drive', 'Indianapolis, IN', '46214-2985 USA', 'Tel.', '(local calls)', 'Tel:', 'Fax:', 'Use for Europe, the Middle East, and Africa:', 'Covance CLS Gen\u00e8ve', 'Rue Mo\u00efse-Marcinhes 7', '1217 Meyrin/Gen\u00e8ve-CH', 'Tel:', 'Fax:', 'Property of the Sanofi Group - strictly confidential', 'Page 104', '(electronic 4.0)']['Amended Clinical Trial Protocol NO 03', '18-Apr-2018', 'ACT14656', 'Version number: 1', 'Property of the Sanofi Group - strictly confidential', 'Page 105', '(electronic 4.0)']\n\n###\n\n", "completion": "END"}